- Home
- ELVN vs PGRE Comparison
ELVN vs PGRE Comparison
Compare ELVN & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PGRE
- Stock Information
- Founded
- ELVN 2016
- PGRE 1978
- Country
- ELVN United States
- PGRE United States
- Employees
- ELVN N/A
- PGRE N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PGRE Real Estate Investment Trusts
- Sector
- ELVN Health Care
- PGRE Real Estate
- Exchange
- ELVN Nasdaq
- PGRE Nasdaq
- Market Cap
- ELVN 1.2B
- PGRE 1.3B
- IPO Year
- ELVN 2020
- PGRE 2014
- Fundamental
- Price
- ELVN $20.73
- PGRE $6.03
- Analyst Decision
- ELVN Strong Buy
- PGRE Hold
- Analyst Count
- ELVN 5
- PGRE 4
- Target Price
- ELVN $41.20
- PGRE $5.38
- AVG Volume (30 Days)
- ELVN 747.2K
- PGRE 2.7M
- Earning Date
- ELVN 08-12-2025
- PGRE 07-30-2025
- Dividend Yield
- ELVN N/A
- PGRE N/A
- EPS Growth
- ELVN N/A
- PGRE N/A
- EPS
- ELVN N/A
- PGRE N/A
- Revenue
- ELVN N/A
- PGRE $711,729,000.00
- Revenue This Year
- ELVN N/A
- PGRE $2.74
- Revenue Next Year
- ELVN N/A
- PGRE N/A
- P/E Ratio
- ELVN N/A
- PGRE N/A
- Revenue Growth
- ELVN N/A
- PGRE 49.28
- 52 Week Low
- ELVN $13.30
- PGRE $3.75
- 52 Week High
- ELVN $30.03
- PGRE $6.62
- Technical
- Relative Strength Index (RSI)
- ELVN 52.08
- PGRE 49.80
- Support Level
- ELVN $19.22
- PGRE $5.96
- Resistance Level
- ELVN $21.90
- PGRE $6.22
- Average True Range (ATR)
- ELVN 1.49
- PGRE 0.16
- MACD
- ELVN -0.19
- PGRE -0.10
- Stochastic Oscillator
- ELVN 39.43
- PGRE 10.62
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.